Bageda Dosage & Drug Information

Concise Prescribing Info

Contents

Leflunomide

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

Adult patients w/ active RA to improve physical function; active psoriatic arthritis.

Dosage/Direction for Use

RA Loading dose: 100 mg once daily for 3 days. Maintenance dose: 10-20 mg once daily depending on severity of disease. Psoriatic arthritis Loading dose: 100 mg once daily for 3 days. Maintenance dose: 20 mg once daily.

Administration

May be taken with or without food: Swallow w/o chewing; w/ sufficient amount of liqd (approx 120 mL).

Contraindications

Hypersensitivity. Severe immunodeficiency states (eg, AIDS). Patients w/ significantly impaired bone marrow function or significant anaemia, leucopenia, neutropenia or thrombocytopenia due to causes other than rheumatoid or psoriatic arthritis; serious infections; severe hypoproteinaemia (eg, nephrotic syndrome). Moderate to severe renal impairment. Liver impairment. Women of childbearing potential who are not using reliable contraception during treatment. Pregnancy & lactation.

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

ATC Classification

L04AK01 - leflunomide ; Belongs to the class of dihydroorotate dehydrogenase (DHODH) inhibitors. Used as immunosuppressants.

Regulatory Classification

POM

Presentation/Packing

Form

Bageda FC tab 20 mg

Packing/Price

1's

Bageda

leflunomide

Manufacturer:

World Medicine